×
Top Dividend Stocks to Buy before the prices go up!
Download Your Free Stock Report!
Our expert team of analysts helps you with Buy, Hold & Sell recommendations!
Our goal is to provide you with best stock market recommendations At the Right Price - At the Right Time
To Get Free Reports Register Now
Register Now
By clicking this button, you agree to our
Terms of Service
and
Privacy Policy
& our Financial Services Guide
(FSG)
×
7 Days Free Trial
Submit
info@aceinvestors.com.au
(02) 9199 9639
Members Login
Contact Us
Home
Research Reports
Daily Recommendations
Dividend Income Report
Growth Stock Report
Speculative Stock Report
US Stock Report
Under 50 cents Special
US Market Report
Segment Specific
Blue Chip
Mid Cap
Small Cap
IPO
Sector Coverage
Banking
Entertainment
Financials
Telecom
Healthcare
Food, Beverage & Tobacco
Insurance
Services and Materials
Technology & IT
IPO
Mining
Energy
Media
Industrial
Utility
Retail
Real Estate
Airlines & Transportation
Consumer Discretionary
Editorial
Sample Report
Subscribe
Privacy Policy
Home
Privacy Policy
Pharmaxis Limited – Pipeline Creates Multip...
By ACE Investors / 13 May 2022
Read More
BWX Limited: Focus on Expanding product Offer...
By ACE Investors / 11 May 2022
Read More
Nova Eye Medical Limited – Comprehensive Po...
By ACE Investors / 10 May 2022
Read More
Paradigm Biopharmaceuticals Ltd (ASX: PAR): U...
By ACE Investors / 05 May 2022
Read More
Resmed Inc. (ASX: RMD): Investments in R&D an...
By ACE Investors / 04 May 2022
Read More
Ramsay Health Care Limited(ASX: RHC): Well Po...
By ACE Investors / 03 May 2022
Read More
Medifast Inc: Scalable Coach-Based Approach T...
By ACE Investors / 28 Apr 2022
Read More
Antisense Therapeutics Limited: ATL1102 Clear...
By ACE Investors / 26 Apr 2022
Read More
Universal Biosensors Inc. – Focused on Deve...
By ACE Investors / 22 Apr 2022
Read More
Lumos Diagnostics Holdings Limited: Possesses...
By ACE Investors / 19 Apr 2022
Read More
Teladoc Health, Inc: Continuous Meaningful Gr...
By ACE Investors / 14 Apr 2022
Read More
Telix Pharmaceuticals Limited (ASX: TLX): App...
By ACE Investors / 07 Apr 2022
Read More
‹ First
<Previous
25
26
27
28
29
Next >
Last ›
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by
Ace Investors